Revenue + Forward P/E
CVS Health Corp. (CVS) quarterly revenue and forward P/EForward P/E: 11.8x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$121.55B
Enterprise value
$206.27B
P/E ratio (TTM)
46.64x
P/S ratio (TTM)
0.34x
P/B ratio
1.77x
EV/Sales
0.51x
EV/EBITDA
18.53x
Dividend yield
2.47%
Income statement (TTM)
Revenue (TTM)
$402.07B
Gross profit (TTM)
$55.36B
Operating income (TTM)
$10.38B
EBITDA (TTM)
$9.86B
Net income (TTM)
$1.77B
Free cash flow (TTM)
$7.81B
Margins & returns
Gross margin
13.87%
Operating margin
1.46%
Profit margin
0.72%
Return on equity
3.87%
Return on assets
1.16%
Per-share metrics
EPS (TTM)
$2.30
Dividend yield
2.47%
Beta
0.60
Capital structure
Cash & equivalents
$8.51B
Total debt
$93.59B
Net debt
$85.08B
Shares outstanding
1.28B
Financial health
Current ratio
0.84
Debt / equity
1.24
Debt / assets
0.36
Interest coverage
3.33
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $629.78B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.08B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.18B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.26B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $121.55B | 46.64x | 0.34x | 18.53x | 2.47% |